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A decade with heart transplantation e Single
centre experience
K.M. Cherian, A.G. Narayanaswamy
Frontier Lifeline Hospital & Dr.K.M. Cherian Heart Foundation, Chennai,
India
Background: Heart transplantation is being done at Frontier Life-
line Hospital & DR. K.M. Cherian Heart Foundation, Chennai since
2004. So far 41 heart transplants have taken place till date.
Methods and Results: A vast majority 80% of the transplant re-
cipients were male. A majority i.e 46% of the transplant recipients
were in the age group of 41 e 60 yrs and 36% of the transplant
recipients are in the age group of 21 e 40 yrs and 17% were in the
age group 0 -20 yrs old.
The major cause for cardiac transplantation is Dilated Cardio-
myopathy in 65% of the patients, Ischemic Cardiomyopathy in
17% and the rest were diagnosed as Restrictive Cardiomyopathy,
Hypertrophic Cardiomyopathy and Cardiac Tumor.
A vast majority 85% of the transplant recipient hearts were
taken from the hospitals in Chennai through ambulance (road)
and the remaining 15% of the hearts were taken from outside
Chennai through flight& ambulance (Vellore, Madurai, Bangalore,
Coimbatore).
Majority of the transplant surgeries were done by Bicaval tech-
nique. Immunosuppressant protocol started with induction in 50%
of patients. Immunosuppressants used were cyclosporine 70%,
tacrolimus 30%, mycophenolate 100% and prednisolone 100%.
No endomyocardial biopsy was done, evaluation of rejection is
done by ECHO criteria only. The causes of death among post
transplant patients were mostly infections, especially fungal in
90%, late rejection occurred 50% of transplant patients, early renal
failure in 70%, Anemia in 10%, complete heart block in 1% and
infection of urinary tract in 10% of patients.
Conclusion: Heart transplantation is here to stay. After changes in
our strategies of induction therapy and modification of immu-
nosuppression, our survival rates have improved.
ECG changes after heart transplantation e Single
center experience of a decade
A.G. Narayanaswamy, S. Anandan, A. Johnson, K.M. Cherian
Frontier Lifeline Hospital & Dr.K.M. Cherian Heart Foundation, Chennai,
India
Background: Frontier Lifeline Hospital & DR. K.M. Cherian Heart
Foundation, Chennai has done maximum number of Heart
Transplants in India to our knowledge. The study reviews the
static and dynamic ECG changes seen in 41 heart transplantation
patients done in our center.
Methods & Results: ECG changes post transplantation can be
divided into two groups.
Fixed ECG changes which persists with the patients all through
his life. These fixed ECG changes appeared first time after heart
transplantation. These changes were right bundle branch block in
26% of patients, left bundle branch block in 10.52% & Sinus
tachycardia 5.26%, right axis deviation in 10.52%, left axis devia-
tion in 5.26%, poor R wave progression in 18.4%, Prolonged PR
interval 5.26%.
Dynamic ECG changes occurring anytime during post heart
transplantation which were of benign prognosis. There were
VPC’s especially VPC’s with LBBB morphology. LAE occurred
usually after 1 year of heart transplantation in 18% patients.
ECG changes major prognostic implication were junctional
tachycardia 2%, prolonged PR interval 8%, prolonged QTC interval
4%, decreased in QRS amplitude of ECG’s which portended a bad
prognosis 20%. Subsequent in size of QRS amplitude meant a
better prognosis. This is perhaps the largest number presented to
our knowledge with Indian patients.
Diagnostic issues in DCM: A proposal for universal
definition based on LV end systolic dimension
Venkatesan Sangareddi, Arun Ranganathan,
Sundar Chidambaram
Madras Medical College, Chennai, India
Background: Dilated cardiomyopathy (DCM) is a common clinical
cardiology problem. Still, there is no uniform definition for this
entity. One popular definition for DCM is based on following pa-
rameters (1)LVEF  45% (2) fractional shortening  25% and (3)
LVEDD  112 % predicted value corrected for age and body surface
area. By tradition we use EDD to define LV dilatation but hemo-
dynamic principles would suggest LV ESD may be ideal to define
DCM as it is less dependent on preload. Further if MR is associated
it can confound LVEDD.
Methods: In this context, we analysed the relationship between
LV ESD, EDD, EF% and the impact of treatment on these parame-
ters. 25 patients with DCM who were attending our OPD were the
subjects of the study.
Table. Documentation of HF medications use from any outpatient encounter in patients with EF ≤40% by various
subgroups.
Medications
(any use)
Men
[N¼ 1225]
Women
[N¼ 3679]
<65 years
[N¼ 11874]
65 years
[N¼ 3949]
Receiving care in
a practice with
EMR [N¼15726]
Receiving care in
practice without
EMR [N¼214]
History of MI
[N¼ 2758]
No history of
MI [N¼ 13182]
ACE-I or ARB
n, (%)
4232(34.5) 1025(27.9) 3804(32.0) 1418(35.9) 5197(33.1) 60 (28.0) 1408(51.1) 3849 (29.2)
Beta blockers
n, (%)
4381(35.7) 1069(29.1) 3949(33.3) 1486(37.6) 5407(34.4) 43 (20.1) 1454(52.7) 3996 (30.3)
ACE-I/ARB and
beta blocker
n, (%)
3768(30.7) 879(23.9) 3366(28.4) 1273 (32.2) 4630(29.4) 17 (7.9) 1342 (48.7) 3305 (25.1)
ACE-I: angiotensin converting enzyme inhibitor, ARB: angiotensin receptor blocker, EF: ejection fraction, EMR: electronic medical record, HF:
heart failure, MI: myocardial infarction
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Results: Male female ratio was 4:1 and age group (24-58y). The
mean ESDwas 63 (56-78) Mean EDDwas 50 (46-54). However at the
mean ESD of 50 mm the EDD was quiet variable between (58-
72mm).We observed EDD to scatter much from themean and ESD
showed less variation. The LVEFwas linearly correlating with both
EDD and ESD. Severe LV dysfunction (< 25 %) was more related to
larger ESDs. When mitral regurgitation was present ESD were
better correlated with LV dysfunction. The impact of intensive
medical management on LV dimension was also studied in 5 pa-
tients. The regression of EDD was more rapid than ESD .An
empirical reduction > 5mm in ESD was considered significant. It
was achieved only in two, while EDD regression was documented
in all. Functional class improvement and 6 minute walk test
showed a positive trend only in patients whose ESD regressed.
Conclusions: We conclude LVESD is amore scientific parameter to
diagnose DCM than LVEDD. It is also a better index to assess and
follow-up these patients. In our series, a mean LVESD of more
than 50 mm predicted all significant DCMs .We suggest there is a
need for a larger study on this issue. We may universalize the
definition of DCM based on LVESD rather than LVEDD.
Is the pleotropic effect of ranolazine is due to its
antioxidant action?
Janapati Ramakrishna, M. Jyotsna, D. Seshagiri Rao
Nizams Institute of Medical Sciences, Hyderabad, India
Background: Ranolazine is a unique anti anginal drug with un-
defined mechanisms of action. In the present study we were
aimed to identify the role of ranolazine in improving left ven-
tricular function by various echocardiographic parameters and to
identify its effect on a unique oxidative stress marker Malo-
naldehyde in patients with post myocardial infarction left ven-
tricular dysfunction who underwent revascularization by
percutaneous interventions.
Methods: Prospectively one hundred (100) cases and forty (40)
controls with LV dysfunction were recruited in this study with 6
months of follow up and all baseline and demographic parame-
ters, clinical features and symptomatology with blood chemistry
parameters were collected for all patients. All patients underwent
detailed echocardiography at baseline and at 6 months and serum
Malonaldehyde levels were also analyzed at baseline and 6
months. The echocardiographic parameters studied were ejection
fraction [{LV volume in end diastole (LVEDV) - LV volume in end
systole (LVESV)}/ LVEDV}, fractional shortening ((LVEDd-LVESd) /
LVEDd expressed as a percentage e d is dimension) and peak
mitral annular velocity (degree of movement of mitral annulus
during systole e PMAV) by Doppler. Malondialdehyde (MDA) is
one of the most frequently used indicators of lipid peroxidation.
We used plasma MDA levels to know the degree of oxidative
stress. MDA concentration will be determined by using the
method described by Draper and Hadley based on TBA reactivity.
Normal Range of MDA is 3.60 ± 0.90 nanomole/ml . Controls
received standard medical therapy alone after PCI where as cases,
in addition, received 500 milligrams of Ranolazine twice a day for
6 months. All Echocardiographic parameters were reassessed
after 6months andmalonaldehyde concentrationswere repeated.
Minitab 16 version is used for statistical analysis.
Results: Male: Female ratio was 3.4:1 in cases and in controls. The
mean age of cases was 56.8 ± 9.6 yrs in cases and 55.1 ± 12 yrs in
controls. Basal clinical demographic features and risk factors are
comparable between cases and controls. After 6 months of Rano-
lazine therapy there was a statistically significant improvement in
EF{(46.1±10.5) to (48.32±9.63%)} and {(44.2±10.8)to (43.85±8.38%)}(
p¼0.008) by diameter and volume [(43.8±9.3) to (46.72±9.34ml)] and
[(41.8±9.52) to (42.55±9.1 ml)] p¼0.018) in cases and controls
respectively in comparison to baseline and there was improve-
ment in MAV [(9.5±2.1) to (9.79±1.84)] and [(8.8±1.8) to (8.65±1.8)]
(p¼0.001) in cases and controls respectively indicating the positive
remodeling effects of drug on LV parameters Plasma MDA levels
also showed improvement in cases than in controls. MDA at 6
months in cases was decreased from 3.6 nanomole/dl to 3.4±0.8
nanomole/dl where as in controls increased 3.8 to 3.9±0.7 nano-
mole/dl. Analysis of variance (ANOVA) was performed to check
whether there is any significant difference between the basal
values, 6 months control & with drug. It can be inferred from the
study that theeffect ofRanolazineon left ventricular remodeling in
obstructive coronary artery disease patients is highly significant
(p¼0.001 ) and has the potential to reduce the risk considerably.
Conclusions: Peak Mitral velocities can be used to follow the cases
in clinical practice to know the improvement in LV contractility
like standard EF. There is significant improvement in EF in cases
when compared to controls at 6 months, reconfirming the results
from the PMAV analysis. There is reduction in oxidative stress
levels in cases than controls at 6 months, may be possible
mechanism of action of ranolazine induced positive LV remodel-
ing.
Risk stratification of women with peripartum
cardiomyopathy at initial presentation: A
dobutamine stress echocardiography study
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L.S.R. Krishna, M. Adithya
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Background: Peripartum cardiomyopathy is a rare disorder
effecting women in their prime years of life. There appears to be
an initial high-risk period with 25% to 50% of women dying within
the first 3 months postpartum. Early risk stratification and prog-
nostication are, thus, crucial. However, only limited data are
available.
Objectives: We sought to determine the prognostic use of
inotropic contractile reserve on risk stratification and prognosti-
cation of women with peripartum cardiomyopathy.
Methods: In all, 10 women (mean age 20.7 years) with peripartum
cardiomyopathy and severe left ventricular (LV) dysfunction
(mean LV ejection fraction [LVEF] 27.3 + 6.5%) were studied. Of
these, 8 underwent dobutamine stress echocardiography at
baseline and a follow-up resting echocardiogram at a mean of 3.6
+ 0.9 months after initial presentation. Resting and peak inotropic
contractile reserve, and follow-up LVEF, were computed.
Results: Themean LVEF improved significantly frombaseline (27.3
+ 6.5%) to maximal inotropic contractile reserve (52.6 + 11.2%) (P _
.0004) and at follow-up (54.2 _ 14.3%) (P _ .006). Importantly, LVEF
at maximal inotropic contractile reserve and at follow-up (3.6
months) did not differ significantly. The mean LVEF at maximal
inotropic contractile reserve correlated well with the follow- up
(LVEF R _ 0.79). However, the baseline LVEF did not correlate with
follow-up LVEF.
Conclusions: In patients presenting with peripartum cardiomy-
opathy, inotropic contractile reserve during dobutamine stress
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